Coston McIsaac & Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81K | Buy |
1,183
+6
| +0.5% | +$411 | 0.02% | 234 |
|
|
2025
Q1 | $79K | Buy |
1,177
+7
| +0.6% | +$470 | 0.02% | 217 |
|
|
2024
Q4 | $52K | Buy |
1,170
+8
| +0.7% | +$356 | 0.02% | 268 |
|
|
2024
Q3 | $73 | Buy |
1,162
+93
| +9% | +$6 | 0.02% | 227 |
|
|
2024
Q2 | $63K | Buy |
1,069
+345
| +48% | +$20.3K | 0.02% | 230 |
|
|
2024
Q1 | $57K | Buy |
724
+185
| +34% | +$14.6K | 0.02% | 249 |
|
|
2023
Q4 | $42K | Buy |
539
+161
| +43% | +$12.5K | 0.01% | 286 |
|
|
2023
Q3 | $26K | Buy |
378
+3
| +0.8% | +$206 | 0.01% | 343 |
|
|
2023
Q2 | $25K | Buy |
375
+3
| +0.8% | +$200 | 0.01% | 378 |
|
|
2023
Q1 | $27K | Buy |
372
+2
| +0.5% | +$145 | 0.01% | 363 |
|
|
2022
Q4 | $34 | Buy |
370
+2
| +0.5% | – | 0.01% | 335 |
|
|
2022
Q3 | $35K | Buy |
368
+1
| +0.3% | +$95 | 0.02% | 269 |
|
|
2022
Q2 | $34K | Buy |
+367
| New | +$34K | 0.02% | 166 |
|